These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29671261)

  • 1. Using the 2A Protein Coexpression System: Multicistronic 2A Vectors Expressing Gene(s) of Interest and Reporter Proteins.
    Luke GA; Ryan MD
    Methods Mol Biol; 2018; 1755():31-48. PubMed ID: 29671261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of 2A-linked multicistronic cassettes by recombinant PCR.
    Szymczak-Workman AL; Vignali KM; Vignali DA
    Cold Spring Harb Protoc; 2012 Feb; 2012(2):251-4. PubMed ID: 22301657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient multicistronic lentiviral vectors with peptide 2A sequences.
    Ibrahimi A; Vande Velde G; Reumers V; Toelen J; Thiry I; Vandeputte C; Vets S; Deroose C; Bormans G; Baekelandt V; Debyser Z; Gijsbers R
    Hum Gene Ther; 2009 Aug; 20(8):845-60. PubMed ID: 19419274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and construction of 2A peptide-linked multicistronic vectors.
    Szymczak-Workman AL; Vignali KM; Vignali DA
    Cold Spring Harb Protoc; 2012 Feb; 2012(2):199-204. PubMed ID: 22301656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verification of 2A peptide cleavage.
    Szymczak-Workman AL; Vignali KM; Vignali DA
    Cold Spring Harb Protoc; 2012 Feb; 2012(2):255-7. PubMed ID: 22301658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the viral 2A peptide for bicistronic expression in transgenic mice.
    Trichas G; Begbie J; Srinivas S
    BMC Biol; 2008 Sep; 6():40. PubMed ID: 18793381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 2A peptide-based strategies in the design of multicistronic vectors.
    Szymczak AL; Vignali DA
    Expert Opin Biol Ther; 2005 May; 5(5):627-38. PubMed ID: 15934839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Gaussia luciferase and foot-and-mouth disease virus 2A translational interrupter chimeras as polycistronic reporters for transgene expression.
    Puckette M; Burrage T; Neilan JG; Rasmussen M
    BMC Biotechnol; 2017 Jun; 17(1):52. PubMed ID: 28606077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative comparison of expression for genes linked in bicistronic vectors via ires or 2A-peptide of porcine teschovirus-1 sequence].
    Kuzmich AI; Vvedenskiĭ AV; Kopantsev EP; Vinogradova TV
    Bioorg Khim; 2013; 39(4):454-65. PubMed ID: 24707727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
    Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice.
    Kim JH; Lee SR; Li LH; Park HJ; Park JH; Lee KY; Kim MK; Shin BA; Choi SY
    PLoS One; 2011; 6(4):e18556. PubMed ID: 21602908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of multicistronic HIV-1 based lentiviral vectors.
    Chinnasamy N; Shaffer J; Chinnasamy D
    Methods Mol Biol; 2009; 515():137-50. PubMed ID: 19378113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
    Furler S; Paterna JC; Weibel M; Büeler H
    Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system.
    Osborn MJ; Panoskaltsis-Mortari A; McElmurry RT; Bell SK; Vignali DA; Ryan MD; Wilber AC; McIvor RS; Tolar J; Blazar BR
    Mol Ther; 2005 Sep; 12(3):569-74. PubMed ID: 15964244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous peptide and protein expression levels using retroviral vectors in human cells.
    Sandrock TM; Risley B; Richards BT; Poritz MA; Austin HA; Yoo S; Kim MK; Roth B; Repetny K; Hsu F; Stump M; Teng DH; Kamb A
    Mol Ther; 2001 Nov; 4(5):398-406. PubMed ID: 11708876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of translation initiation using a translation control reporter system.
    Wiesenthal V; Leutz A; Calkhoven CF
    Nat Protoc; 2006; 1(3):1531-7. PubMed ID: 17406445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of a membrane-targeting protein translated from a downstream gene of a "self-cleaving" T2A peptide conjunction.
    Hadpech S; Jinathep W; Saoin S; Thongkum W; Chupradit K; Yasamut U; Moonmuang S; Tayapiwatana C
    Protein Expr Purif; 2018 Oct; 150():17-25. PubMed ID: 29733907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive monitoring of target gene expression by imaging reporter gene expression in living animals using improved bicistronic vectors.
    Wang Y; Iyer M; Annala AJ; Chappell S; Mauro V; Gambhir SS
    J Nucl Med; 2005 Apr; 46(4):667-74. PubMed ID: 15809490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector.
    Liu Z; Chen O; Wall JBJ; Zheng M; Zhou Y; Wang L; Vaseghi HR; Qian L; Liu J
    Sci Rep; 2017 May; 7(1):2193. PubMed ID: 28526819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of all-in-one multicistronic Tet-On lentiviral vectors for inducible co-expression of two transgenes.
    Huang Y; Zhen R; Jiang M; Yang J; Yang Y; Huang Z; Lin Y
    Biotechnol Appl Biochem; 2015; 62(1):48-54. PubMed ID: 24825511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.